The risk of developing irritable bowel syndrome (IBS) is greater among people who weighed less than 1,500 g at birth compared to those who weighed more than 1,500 g, and patients with a lower birthweight tend to develop the condition earlier than their heavier counterparts, according to study findings published online Sept. 28 in Gut.
The risk of developing irritable bowel syndrome (IBS) is greater among people who weighed less than 1,500 g at birth compared to those who weighed more than 1,500 g, and patients with a lower birthweight tend to develop the condition earlier than their heavier counterparts, according to study findings published online Sept. 28 in Gut.
Jennifer R. Harris, PhD, of the Norwegian Institute of Public Health in Oslo, Norway, and colleagues conducted a postal questionnaire of 12,700 Norwegian twins born in the 1960s and 1970s, with a 31-item checklist of illnesses and symptoms including IBS. In order to test the association between intrauterine growth and IBS, the investigators analyzed data from discordant monozygotic pairs.
Among the monozygotic pairs, there was 22.4% concordance with IBS, versus only 9.1% among dizygotic twins. After adjustment, subjects with low birthweight (below 1,500 g) were 2.4 times more likely to have IBS than those with a heavier birthweight. The symptoms developed 7.7 years earlier in subjects with low birthweight compared to those patients with higher birthweight.
Bengtson M-B, Ronning T, Vatn M, et al. IBS in twins: genes and environment. Gut. Published Online First: 28 September 2006. doi:10.1136/gut.2006.097287.
Unlocking HPV prevention: Insights from 2022 data on vaccination trends
May 14th 2024Explore the latest findings revealing vaccination rates among children aged 9 to 17 years, uncovering demographic disparities and highlighting the crucial role of vaccination in combating human papillomavirus infections and related health risks.
Read More
Prenatal cannabis and nicotine use linked to adverse pregnancy outcomes
May 14th 2024A recent study highlights the heightened risks of maternal and neonatal morbidity and mortality associated with combined cannabis and nicotine use during pregnancy, urging further investigation into their impact on short- and long-term outcomes.
Read More
Understanding pediatric STIs: Trends, management, and more
May 10th 2024Dive into the rising prevalence of sexually transmitted infections among adolescents and young adults, exploring educational gaps, vaccination rates, and the imperative need for open conversations between patients and health care providers to combat stigma and enhance preventive care.
Read More
No link found between antenatal corticosteroids and child neurodevelopment
April 25th 2024A recent study found no link between antenatal corticosteroid administration and adverse neurodevelopmental outcomes in children aged 6 years or older, offering reassurance for late preterm delivery practices.
Read More